Growth Inov is a private equity fund that looks for innovative solutions resulting from R&D that can guarantee the target company intrinsic value and a growth strategy independent from macro or industry growth. The fund is incorporated for a fixed term under the terms and in accordance with Law no. 18/2015 of March 4, and regulated by CMVM. It is a private equity investment fund whose assets are used for the acquisition, for a limited period of time, of equity instruments and quasi equity in small and medium-sized companies developing R&D projects.
The fund is focused exclusively on companies certified by the National Agency for Innovation (ANI) as suitable for Research and Development (R&D), thus allowing the investors of Growth INOV to benefit from the tax incentive SIFIDE. The tax incentive SIFIDE allows corporate investors to benefit from a Corporate Income Tax (CIT) credit of up to 82,5% of the money invested in the Fund.
Through Growth Inov, GP Capital is actively contributing to increase the investment in R&D in Portugal. The subscription period ended in December 2021.
Growth INOV will invest in SMEs across all sectors in areas that meet global evolution and are aligned with major global trends. It seeks SMEs with significant growth opportunities, in which Portugal has clear competitive advantages, anticipating realistic exit opportunities. We are looking for companies with strong and diversified teams, with pertinent know-how and innovative solutions resulting from R&D.
Our investment will reinforce the target company’s investment in R&D and help in the transition from an R&D project to a global market growth strategy, whether it’s a product, service or a process.